debabrata
●    

2005-10-19 06:58
(5380 d 08:38 ago)

Posting: # 42
Views: 18,342
 

 Investigational Products for BA/BE [Regulatives / Guidelines]

According to Canadian Regulatory requirement, what is the retention sample quantity that has to be kept in the CRO after completion of the study? Also what is the retention period?
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2005-10-19 11:22
(5380 d 04:14 ago)

@ debabrata
Posting: # 43
Views: 17,654
 

 Investigational Products for BA/BE

Hi!

'Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format' (Draft Guidance, 2004-05-12) states:

Retention of Samples
It is recommended that samples of the test and reference drug products used in the comparative bioavailability study(ies), and the biological samples collected, including QC samples, be retained until the submission is either cleared or withdrawn.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
debabrata
●    

2005-10-20 07:22
(5379 d 08:15 ago)

@ debabrata
Posting: # 44
Views: 14,149
 

 Investigational Products for BA/BE

» According to Canadian Regulatory requirement, what is the retention sample quantity that has to be kept in the CRO after completion of the study? Also what is the retention period?

Is there any specific retention quantity that has to be kept in the CRO like US FDA?
H_Rotter
★    

Germany,
2005-10-20 15:43
(5378 d 23:53 ago)

@ debabrata
Posting: # 45
Views: 13,962
 

 Investigational Products for BA/BE

I don't think so; have you considered asking HPFB?

Regards,
Hermann
Activity
 Admin contact
20,819 posts in 4,356 threads, 1,447 registered users;
online 15 (1 registered, 14 guests [including 8 identified bots]).
Forum time: 15:37 CEST (Europe/Vienna)

Statistics are no substitute for judgment.    Henry Clay

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5